The Abstract Submission Deadline is February 18, 2021 at midnight PST.
ABSTRACT SUBMISSION NOTES:
Abstracts are limited to 1830 characters (including spaces, but not including title, authors and affiliations).
The Abstract Submission Fee is $75 for Student Members and $100 for all other submissions. Abstract fees are non-refundable.
Be sure to have your AChemS membership number (or the membership number of your sponsor) prior to starting the abstract submission process.
Accepted abstract presentations will be viewable online from April 19th until May 19th. Only registered conference participants will be able to access presentations.
VIRTUAL POSTER PRESENTERS: Virtual poster presentations include the required JPG/PDF poster, as well as, an optional 5-minute video presentation. Both of these components may be exported directly from Microsoft PowerPoint. While there are no required dimensions for your poster, we suggest using the 4:3 PowerPoint slide format. If desired, poster presenters may also host office hours during which they will be available to discuss their findings with meeting attendees.
VIRTUAL ORAL ABSTRACT PRESENTERS: Oral abstract sessions will follow a standard format. Each session will include eight (8) speakers selected from abstract submissions. Each presenter will give talks of 12 minutes (plus 3 minutes for questions).
ABSTRACT ELIGIBILITY RULES
Each abstract must be sponsored by a member of AChemS. A member of AChemS may sponsor only one abstract.
An individual may appear as first author on only one abstract and may present only one abstract at the
meeting; the first author does not have to be a member.
It is the responsibility of the presenting author and sponsor to ensure that all authors have given their consent to be listed on the submitted version of the abstract. If the presenting author/sponsor is found to be in violation of this rule, they may not be allowed to submit abstracts at future meetings.
The work reported in the abstract should be original research. Abstracts should generally not be submitted to the meeting if the work has been previously published.
To facilitate scientific communication, abstracts reporting studies with unidentified drugs, chemical compounds, or materials will not be accepted. All drugs, chemical compounds, and materials should be identified both in the abstract and during the meeting.